Tumor heterogeneity
Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications
11
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
15
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
14
Quantitative analyses to study tumor clones dynamics and tumor heterogeneity
88
Understanding tumor heterogeneity as functional compartments superorganisms revisited
11
Tumor heterogeneity measurement using [18F] FDG PET/CT shows prognostic value in patients with non-small cell lung cancer
9
Breast cancer intra tumor heterogeneity
11
Tumor heterogeneity in neoplasms of breast, colon, and skin
9
Ultradeep analysis of tumor heterogeneity in regions of somatic hypermutation
17
Human Cancer Modeling: Recapitulating Tumor Heterogeneity Towards Personalized Medicine
10
Evolving concepts of tumor heterogeneity
8
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
17
Using single-cell multiple omics approaches to resolve tumor heterogeneity
16
Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine
15
Alterations of lymph nodes evaluation after colon cancer
12
Evaluation and consequences of heterogeneity in the circulating tumor cell compartment
19
<p>Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a “PET biopsy” method</p>
9
The global cancer genomics consortium’s symposium: new era of molecular medicine and epigenetic cancer medicine - cross section of genomics and epigenetics
8
A Simple Computed Tomography Scoring System to Predict Histological Malignancy of Solitary Fibrous Tumors of the Pleura
8
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site
14